Summary
The National Institutes of Health (NIH) is soliciting research grant applications under the R61/R33 phased innovation award mechanism focused on prevention and intervention approaches for Fetal Alcohol Spectrum Disorders (FASDs). The R61 phase supports milestone-driven developmental/exploratory research, while the R33 phase supports expanded research following successful completion of R61 milestones. Clinical trials are optional under this funding opportunity announcement (FOA). The opportunity is open from November 2024 through November 2026, allowing multiple submission cycles.